JORGE CASTILLO to Biomarkers, Tumor
This is a "connection" page, showing publications JORGE CASTILLO has written about Biomarkers, Tumor.
Connection Strength
1.077
-
CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis. Am J Hematol. 2015 Mar; 90(3):E49-50.
Score: 0.275
-
Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru. Appl Immunohistochem Mol Morphol. 2012 Mar; 20(2):196-200.
Score: 0.224
-
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma. Leuk Res. 2021 03; 102:106513.
Score: 0.104
-
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 04; 95(4):435-445.
Score: 0.097
-
Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma. 2018 06; 59(6):1375-1383.
Score: 0.082
-
Plasma fatty acid profile in multiple myeloma patients. Leuk Res. 2015 Apr; 39(4):400-5.
Score: 0.068
-
Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement. Am J Dermatopathol. 2014 Nov; 36(11):e189-93.
Score: 0.067
-
HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):185-9.
Score: 0.053
-
Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leuk Res. 2011 Mar; 35(3):334-9.
Score: 0.051
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. J Clin Oncol. 2023 03 01; 41(7):1383-1392.
Score: 0.029
-
Venetoclax in Previously Treated Waldenstr?m Macroglobulinemia. J Clin Oncol. 2022 01 01; 40(1):63-71.
Score: 0.027